
CSO Pricing Models: What You'll Actually Pay in 2026
FTE pricing, hourly contracts, and commission models compared. What pharma and device companies actually pay CSOs in 2026, and where the hidden fees sit.

FTE pricing, hourly contracts, and commission models compared. What pharma and device companies actually pay CSOs in 2026, and where the hidden fees sit.

Commission to a 1099 medical sales rep on federal-program business is a known anti-kickback risk. Here is what the personal services safe harbor requires, and why hourly is the cleaner structure.

Managing a 1099 Medical Sales Contractor Versus a W2 Rep: What Actually Changes

A look at the math on testing new geographic territories with contract reps before committing to W2 hires at Series A.

Commission-based 1099 medical sales reps and AKS risk in 2025. What 42 U.S.C. § 1320a-7b(b) and 42 C.F.R. § 1001.952(d) require, what Sorensen and Marchetti changed, and what legal teams should document.

Most companies outsource medical device sales reps the same way twice — the second time with better questions. Here's what the vetting process actually needs to look like, before you sign anything.